- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
-
Still Believe in Antigenics
-
Four Biotech Stocks to Play the Sector Pullback
-
Biotech Sector Pullback: Good Time to Buy at a Discount
-
Investing in Stocks of Various Price Levels: What Really Constitutes a Penny Stock?
-
Antigenics Should Rise on the Promise of Cancer Immunotherapy Treatments
-
Pick Up Antigenics at a Bargain Price
-
Dendreon: New Board Members Appointed, Things Have Never Looked Brighter
-
Stock Watch: CPST, CVM, AGEN
-
Have to Like the Risk / Reward in Antigenics Stock
-
Still a Lot of Potential in Dendreon and the Cancer Immunotherapy Market
-
Antigenics, Cel-Sci Could Both Become Billion Dollar Companies
-
Antigenics: Why So Many Shorts?
-
Cell Therapeutics Looks Good, Antigenics Looks Better
-
Antigenics' Current Price Is Irresistible
-
Antigenics May Finally Be Back on the Uptick
-
Cell Therapeutics Could Be a Real Winner, But Not Right Now
-
BioDelivery Sciences, Antigenics, Cel-Sci All Look Like Winners
-
Stock Watch: VNDA, TTNP.PK, SIRI, CSUH.OB, AGEN
-
As Market Drops, It's Time to Buy
-
Stock Watch: TTNP, VNDA, DNDN, AGEN, ONTY
-
Six Stock Briefs
-
Feuerstein Comments on Antigenics: Weak at Best
-
Investors Show Confidence in Cancer Immunotherapy Stocks
-
Antigenics: The Big Boys Are Buying
-
Understanding Antigenics' Private Placement
-
Biotech Volatility: Antigenics, BioDelivery Sciences
-
Small Biopharma Ponderings
-
3 Biotech Stocks on the Move
-
Biodelivery Sciences, Antigenics: Biotech Stocks That Require Patience
-
5 More Stock Briefs
-
Antigenics: Why I Couldn't Resist Buying on the Dip
-
7 More Stock Briefs
Latest Comments on VFC's Stock House's Articles